vs

Side-by-side financial comparison of FORMFACTOR INC (FORM) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $226.1M, roughly 1.2× FORMFACTOR INC). FORMFACTOR INC runs the higher net margin — 9.0% vs 0.7%, a 8.3% gap on every dollar of revenue. On growth, FORMFACTOR INC posted the faster year-over-year revenue change (32.0% vs -16.5%). FORMFACTOR INC produced more free cash flow last quarter ($30.7M vs $3.4M).

Formfactor, Inc. is a provider of test and measurement technologies for integrated circuits, with its headquarters in Livermore, California. It provides semiconductor companies with products to improve device performance and provide test and measurement technologies for integrated circuits.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

FORM vs HCM — Head-to-Head

Bigger by revenue
HCM
HCM
1.2× larger
HCM
$270.8M
$226.1M
FORM
Growing faster (revenue YoY)
FORM
FORM
+48.5% gap
FORM
32.0%
-16.5%
HCM
Higher net margin
FORM
FORM
8.3% more per $
FORM
9.0%
0.7%
HCM
More free cash flow
FORM
FORM
$27.4M more FCF
FORM
$30.7M
$3.4M
HCM

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FORM
FORM
HCM
HCM
Revenue
$226.1M
$270.8M
Net Profit
$20.4M
$2.0M
Gross Margin
38.4%
37.7%
Operating Margin
7.4%
-13.2%
Net Margin
9.0%
0.7%
Revenue YoY
32.0%
-16.5%
Net Profit YoY
218.5%
-83.6%
EPS (diluted)
$0.26
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FORM
FORM
HCM
HCM
Q1 26
$226.1M
Q4 25
$215.2M
$270.8M
Q3 25
$202.7M
Q2 25
$195.8M
$277.7M
Q1 25
$171.4M
$324.5M
Q4 24
$189.5M
Q3 24
$207.9M
Q2 24
$197.5M
$305.7M
Net Profit
FORM
FORM
HCM
HCM
Q1 26
$20.4M
Q4 25
$23.2M
$2.0M
Q3 25
$15.7M
Q2 25
$9.1M
$455.0M
Q1 25
$6.4M
$11.9M
Q4 24
$9.7M
Q3 24
$18.7M
Q2 24
$19.4M
$25.8M
Gross Margin
FORM
FORM
HCM
HCM
Q1 26
38.4%
Q4 25
42.2%
37.7%
Q3 25
39.8%
Q2 25
37.3%
0.1%
Q1 25
37.7%
48.0%
Q4 24
38.8%
Q3 24
40.7%
Q2 24
44.0%
41.1%
Operating Margin
FORM
FORM
HCM
HCM
Q1 26
7.4%
Q4 25
10.9%
-13.2%
Q3 25
8.9%
Q2 25
6.3%
-1.3%
Q1 25
1.9%
-5.0%
Q4 24
4.1%
Q3 24
8.6%
Q2 24
9.0%
-9.0%
Net Margin
FORM
FORM
HCM
HCM
Q1 26
9.0%
Q4 25
10.8%
0.7%
Q3 25
7.7%
Q2 25
4.6%
163.8%
Q1 25
3.7%
3.7%
Q4 24
5.1%
Q3 24
9.0%
Q2 24
9.8%
8.4%
EPS (diluted)
FORM
FORM
HCM
HCM
Q1 26
$0.26
Q4 25
$0.29
$0.00
Q3 25
$0.20
Q2 25
$0.12
$0.52
Q1 25
$0.08
$0.01
Q4 24
$0.12
Q3 24
$0.24
Q2 24
$0.25
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FORM
FORM
HCM
HCM
Cash + ST InvestmentsLiquidity on hand
$123.5M
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.1B
$1.2B
Total Assets
$1.3B
$1.8B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FORM
FORM
HCM
HCM
Q1 26
$123.5M
Q4 25
$103.3M
$1.4B
Q3 25
$266.0M
Q2 25
$249.3M
$1.4B
Q1 25
$299.0M
$836.1M
Q4 24
$360.0M
Q3 24
$354.5M
Q2 24
$357.6M
$802.5M
Total Debt
FORM
FORM
HCM
HCM
Q1 26
Q4 25
$12.2M
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
$13.3M
Q3 24
Q2 24
$82.1M
Stockholders' Equity
FORM
FORM
HCM
HCM
Q1 26
$1.1B
Q4 25
$1.0B
$1.2B
Q3 25
$1.0B
Q2 25
$990.0M
$1.2B
Q1 25
$965.9M
$759.9M
Q4 24
$947.8M
Q3 24
$955.0M
Q2 24
$947.9M
$740.1M
Total Assets
FORM
FORM
HCM
HCM
Q1 26
$1.3B
Q4 25
$1.2B
$1.8B
Q3 25
$1.2B
Q2 25
$1.2B
$1.8B
Q1 25
$1.2B
$1.3B
Q4 24
$1.1B
Q3 24
$1.2B
Q2 24
$1.2B
$1.3B
Debt / Equity
FORM
FORM
HCM
HCM
Q1 26
Q4 25
0.01×
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
0.01×
Q3 24
Q2 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FORM
FORM
HCM
HCM
Operating Cash FlowLast quarter
$45.0M
$8.2M
Free Cash FlowOCF − Capex
$30.7M
$3.4M
FCF MarginFCF / Revenue
13.6%
1.2%
Capex IntensityCapex / Revenue
6.7%
1.8%
Cash ConversionOCF / Net Profit
2.21×
4.21×
TTM Free Cash FlowTrailing 4 quarters
$37.5M
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FORM
FORM
HCM
HCM
Q1 26
$45.0M
Q4 25
$46.0M
$8.2M
Q3 25
$27.0M
Q2 25
$18.9M
$-72.9M
Q1 25
$23.5M
$40.3M
Q4 24
$35.9M
Q3 24
$26.7M
Q2 24
$21.9M
$-39.8M
Free Cash Flow
FORM
FORM
HCM
HCM
Q1 26
$30.7M
Q4 25
$34.7M
$3.4M
Q3 25
$19.5M
Q2 25
$-47.4M
$-82.2M
Q1 25
$5.0M
$32.5M
Q4 24
$28.3M
Q3 24
$17.8M
Q2 24
$13.5M
$-49.9M
FCF Margin
FORM
FORM
HCM
HCM
Q1 26
13.6%
Q4 25
16.1%
1.2%
Q3 25
9.6%
Q2 25
-24.2%
-29.6%
Q1 25
2.9%
10.0%
Q4 24
14.9%
Q3 24
8.6%
Q2 24
6.8%
-16.3%
Capex Intensity
FORM
FORM
HCM
HCM
Q1 26
6.7%
Q4 25
5.3%
1.8%
Q3 25
3.7%
Q2 25
33.8%
3.3%
Q1 25
10.8%
2.4%
Q4 24
4.0%
Q3 24
4.3%
Q2 24
4.3%
3.3%
Cash Conversion
FORM
FORM
HCM
HCM
Q1 26
2.21×
Q4 25
1.98×
4.21×
Q3 25
1.72×
Q2 25
2.08×
-0.16×
Q1 25
3.68×
3.38×
Q4 24
3.70×
Q3 24
1.43×
Q2 24
1.13×
-1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons